Is detection of bacterial DNA in ascitic fluid of clinical relevance?

Beate Appenrodt1, Lutz E Lehmann, Lydia Thyssen

  • 1Departments of aInternal Medicine I, University of Bonn, Bonn, Germany. beate.appenrodt@ukb.uni-bonn.de

Abstract

Insights

Bacterial DNA in ascites of cirrhosis patients does not correlate with spontaneous bacterial peritonitis (SBP). Current DNA testing lacks clinical relevance for diagnosing SBP in these patients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Bacterial translocation in cirrhosis patients leads to bacterial DNA in ascites.
  • The clinical significance of detecting bacterial DNA in ascites is unclear compared to standard spontaneous bacterial peritonitis (SBP) diagnostics.
  • Existing DNA detection methods require further evaluation.

Purpose of the Study:

  • To investigate the clinical relevance of bacterial DNA detection in ascites of patients with liver cirrhosis.
  • To compare bacterial DNA detection with standard diagnostic methods for spontaneous bacterial peritonitis (SBP).

Main Methods:

  • Prospective study of 151 cirrhosis patients with ascites.
  • Diagnosis of SBP based on polymorphonuclear count (>250 cells/mm³) and bacterial culture.
  • Broad-range polymerase chain reaction and nucleotide sequencing (LightCycler SeptiFast Kit Mgrade) used for bacterial DNA detection in ascites.

Main Results:

  • 12% of patients (18/151) had SBP by classic definition; bacterial DNA was detected in only 3% (5/18) of these.
  • Bacterial DNA was found in 9% (13/151) of patients without SBP.
  • No significant association was found between assessed parameters and bacterial DNA positivity in the ascites group.

Conclusions:

  • No correlation exists between bacterial DNA detection in ascites and SBP diagnosis.
  • Patients with SBP exhibited clinical signs of infection, unlike those with detectable bacterial DNA.
  • The LightCycler SeptiFast Kit Mgrade shows no current clinical or diagnostic utility for detecting bacterial DNA in ascites of liver cirrhosis patients.